![Michael R. McNeely](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Michael R. McNeely active positions
Companies | Position | Start | End |
---|---|---|---|
Gattaco, Inc.
![]() Gattaco, Inc. Medical SpecialtiesHealth Technology Gattaco, Inc. provides a solution for self-collected, lab quality plasma. The company is based in Murrieta, CA. The company's a-pon device allows consumers to convert fingerstick blood to liquid plasma in less than 3 minutes without specialized knowledge or equipment. The plasma obtained fits seamlessly into existing testing workflows without changing established thresholds. Pankaj Singhal has been the CEO of the company since 2022. | Corporate Officer/Principal | 31/12/2013 | - |
Career history of Michael R. McNeely
Former positions of Michael R. McNeely
Companies | Position | Start | End |
---|---|---|---|
BioMicro Systems, Inc.
![]() BioMicro Systems, Inc. BiotechnologyHealth Technology BioMicro® Systems, Inc. is a private company founded in 2000 with expertise in micro fluidics. BioMicro Systems is focused on the development and commercialization of biological research products based on its proprietary micro fluidic handling technologies. The BioMicro Systems, Inc. mission is to apply its expertise in creating novel technologies to address customer requirements for improved data quality, throughput and laboratory effectiveness. They will build a superior organization to enhance the value of BioMicro Systems to its customers, employees, partners, and shareholders. BioMicro Systems, Inc. was founded in 2000 and is based in Salt Lake City, Utah. BioMicro Systems is a private company that serves the life sciences community by developing and marketing biological research products based on its proprietary micro fluidic and microarray technologies. In 2003 BioMicro Systems launched the MAUI Hybridization System, a cutting-edge microarray hybridization instrument, designed to alleviate the processing bottleneck encountered during the microarray hybridization process and to help researchers achieve greater sensitivity and more consistent/reproducible results. BioMicro Systems has recently expanded its product portfolio to include the all-new MAUI Wash System and Kreatech labeling kits. BioMicro Systems strives to become the company to provide the standard for achieving superb microarray hybridization results. | Founder | 31/12/1999 | - |
Statistics
International
United States | 3 |
Operational
Founder | 1 |
Corporate Officer/Principal | 1 |
Sectoral
Health Technology | 3 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
Private companies | 2 |
---|---|
BioMicro Systems, Inc.
![]() BioMicro Systems, Inc. BiotechnologyHealth Technology BioMicro® Systems, Inc. is a private company founded in 2000 with expertise in micro fluidics. BioMicro Systems is focused on the development and commercialization of biological research products based on its proprietary micro fluidic handling technologies. The BioMicro Systems, Inc. mission is to apply its expertise in creating novel technologies to address customer requirements for improved data quality, throughput and laboratory effectiveness. They will build a superior organization to enhance the value of BioMicro Systems to its customers, employees, partners, and shareholders. BioMicro Systems, Inc. was founded in 2000 and is based in Salt Lake City, Utah. BioMicro Systems is a private company that serves the life sciences community by developing and marketing biological research products based on its proprietary micro fluidic and microarray technologies. In 2003 BioMicro Systems launched the MAUI Hybridization System, a cutting-edge microarray hybridization instrument, designed to alleviate the processing bottleneck encountered during the microarray hybridization process and to help researchers achieve greater sensitivity and more consistent/reproducible results. BioMicro Systems has recently expanded its product portfolio to include the all-new MAUI Wash System and Kreatech labeling kits. BioMicro Systems strives to become the company to provide the standard for achieving superb microarray hybridization results. | Health Technology |
Gattaco, Inc.
![]() Gattaco, Inc. Medical SpecialtiesHealth Technology Gattaco, Inc. provides a solution for self-collected, lab quality plasma. The company is based in Murrieta, CA. The company's a-pon device allows consumers to convert fingerstick blood to liquid plasma in less than 3 minutes without specialized knowledge or equipment. The plasma obtained fits seamlessly into existing testing workflows without changing established thresholds. Pankaj Singhal has been the CEO of the company since 2022. | Health Technology |
- Stock Market
- Insiders
- Michael R. McNeely
- Experience